Status of vaccine research and development of vaccines for dengue
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Interactions between serotypes of dengue highlight epidemiological impact of cross-immunityJournal of The Royal Society Interface, 2013
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cellsProceedings of the National Academy of Sciences, 2013
- The Synergistic Effect of Combined Immunization with a DNA Vaccine and Chimeric Yellow Fever/Dengue Virus Leads to Strong Protection against DenguePLOS ONE, 2013
- Cost of production of live attenuated dengue vaccines: A case study of the Instituto Butantan, Sao Paulo, BrazilVaccine, 2012
- Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue feverVaccine, 2011
- Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccineVaccine, 2011
- The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced diseaseVaccine, 2011
- Health Economics of Dengue: A Systematic Literature Review and Expert Panel's AssessmentThe American Journal of Tropical Medicine and Hygiene, 2011
- Economic Impact of Dengue Illness in the AmericasThe American Journal of Tropical Medicine and Hygiene, 2011
- The Impact of the Demographic Transition on Dengue in Thailand: Insights from a Statistical Analysis and Mathematical ModelingPLOS Medicine, 2009